Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations

The aim of the study was to assess and compare the clinical efficacy of clindamycin versus clindamycin plus rifampicin in HS patients, after 8 weeks of treatment, according to Hidradenitis Suppurativa Clinical Response measure. Study results suggest that clindamycin in mono-therapy may be a useful and safety alternative to the combination of clindamycin and rifampicin regardless of the clinical stage of HS.

https://ift.tt/2BEaj6N